Mylan settles patent litigation with Novo Nordisk over generic Ozempic in United States
- Posted on October 7, 2024
- By Financial Express
- 2 Views
Mylan settles patent litigation with Novo Nordisk over generic Ozempic in United States
Novo Nordisk had filed a patent infringement suit against Mylan over Ozempic in a US court.
